lunes, 3 de julio de 2023
Drug Trials Snapshots: BREXAFEMME (ibrexafungerp)
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-brexafemme
BREXAFEMME is a drug used for the treatment of vaginal yeast infection (vulvovaginal candidiasis) in adult or adolescent females who have already begun having monthly menstrual cycles.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario